Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant. (2022)

First Author: Andrews N
Attributed to:  MRC Centre for Global Infectious Disease Analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa2119451

PubMed Identifier: 35249272

Publication URI: http://europepmc.org/abstract/MED/35249272

Type: Journal Article/Review

Volume: 386

Parent Publication: The New England journal of medicine

Issue: 16

ISSN: 0028-4793